Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group

Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, M. Govoni, Francisco Javier Lopez Longo, Franco Franceschini, Rossella Neri, Santos Castañeda, Walter Alberto Sifuentes Giraldo, Roberto Caporali, Florenzo Iannone, Enrico Fusaro, G. Paolazzi, Raffaele Pellerito, Andreas Schwarting, Lesley Ann Saketkoo, Norberto Ortego-Centeno, Luca Quartuccio, Elena Bartoloni, Christof SpeckerTrinitario Pina Murcia, R. La Corte, Federica Furini, Valentina Foschi, Javier Bachiller Corral, Paolo Airo, Ilaria Cavazzana, Julia Martínez-Barrio, Michelle Hinojosa, Margherita Giannini, Simone Barsotti, Julia Menke, Kostantinos Triantafyllias, Rosetta Vitetta, Alessandra Russo, Laura Bogliolo, Gian Luigi Bajocchi, E. Bravi, Giovanni Barausse, Roberto Bortolotti, Carlo Francesco Selmi, Simone Parisi, F. Salaffi, Carlomaurizio Montecucco, Miguel A. González-Gay, Behalf Of Aeneas (American On Behalf Of Aeneas (American

Research output: Contribution to journalArticle

Abstract

Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD), an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). Recently, we organized an international collaborative group called American and European NEtwork of Antisynthetase Syndrome (AENEAS) for the study of this rare and fascinating disease. The group collected and published one of the largest series of ASSD patients ever described and with one of the longer follow-up ever reported. The number of participating centers is steadily increasing, as well as the available cohort. In the first paper, we showed that arthritis, myositis, and ILD may be frequently the only feature at disease onset, raising problems to reach a correct diagnosis of this syndrome. Nevertheless, we first observed that the ex novo appearance of further manifestations is common during the follow-up, strengthening the importance of a correct diagnosis. In our cohort, the 24 % of the 243 patients up to now collected had isolated arthritis as a presenting feature. These patients represent the most intriguing group in terms of differential diagnosis and clinical time course. Furthermore, data on this aspect are scanty, the reason that lead us to evaluate these aspects in our cohort of patients, reviewing also available literature. In fact, the most relevant aspect is that ASSD is rarely suspected in this setting of patients, in particular in case of poliarticular involvement, positive rheumatoid factor (RF), or anti-cyclic citrullinated peptide antibodies (ACPA) or evidence of joint erosions at plain radiographs. These findings were not rare in our cohort, and they have been also described in other series. Furthermore, manifestations such as Raynaud’s phenomenon, mechanic’s hands, and fever that may lead to the suspect of ASSD are observed only in a third of cases. If we consider the high rate of clinical picture progression in these patients, we feel that ASSD should be carefully considered in all patients presenting with isolated arthritis, even in those with erosive, RF, and ACPA-positive arthritis.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalClinical Reviews in Allergy and Immunology
DOIs
Publication statusAccepted/In press - Jan 19 2016

Fingerprint

Autoantibodies
Arthritis
Serum
Myositis
Rheumatoid Factor
Interstitial Lung Diseases
Antibodies
Raynaud Disease
Rare Diseases
Antisynthetase syndrome
Mechanics
Autoimmune Diseases
Differential Diagnosis
Fever
Hand
Joints

Keywords

  • Anti-cyclic citrullinated peptide
  • Anti-Jo-1
  • Antisynthetase syndrome
  • Clinical time course
  • Isolated polyarthritis
  • Rheumatoid factor

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome : Review of the Literature and Report of the Experience of AENEAS Collaborative Group. / Cavagna, Lorenzo; Nuño, Laura; Scirè, Carlo Alberto; Govoni, M.; Longo, Francisco Javier Lopez; Franceschini, Franco; Neri, Rossella; Castañeda, Santos; Sifuentes Giraldo, Walter Alberto; Caporali, Roberto; Iannone, Florenzo; Fusaro, Enrico; Paolazzi, G.; Pellerito, Raffaele; Schwarting, Andreas; Saketkoo, Lesley Ann; Ortego-Centeno, Norberto; Quartuccio, Luca; Bartoloni, Elena; Specker, Christof; Pina Murcia, Trinitario; La Corte, R.; Furini, Federica; Foschi, Valentina; Bachiller Corral, Javier; Airo, Paolo; Cavazzana, Ilaria; Martínez-Barrio, Julia; Hinojosa, Michelle; Giannini, Margherita; Barsotti, Simone; Menke, Julia; Triantafyllias, Kostantinos; Vitetta, Rosetta; Russo, Alessandra; Bogliolo, Laura; Bajocchi, Gian Luigi; Bravi, E.; Barausse, Giovanni; Bortolotti, Roberto; Selmi, Carlo Francesco; Parisi, Simone; Salaffi, F.; Montecucco, Carlomaurizio; González-Gay, Miguel A.; On Behalf Of Aeneas (American, Behalf Of Aeneas (American.

In: Clinical Reviews in Allergy and Immunology, 19.01.2016, p. 1-10.

Research output: Contribution to journalArticle

Cavagna, L, Nuño, L, Scirè, CA, Govoni, M, Longo, FJL, Franceschini, F, Neri, R, Castañeda, S, Sifuentes Giraldo, WA, Caporali, R, Iannone, F, Fusaro, E, Paolazzi, G, Pellerito, R, Schwarting, A, Saketkoo, LA, Ortego-Centeno, N, Quartuccio, L, Bartoloni, E, Specker, C, Pina Murcia, T, La Corte, R, Furini, F, Foschi, V, Bachiller Corral, J, Airo, P, Cavazzana, I, Martínez-Barrio, J, Hinojosa, M, Giannini, M, Barsotti, S, Menke, J, Triantafyllias, K, Vitetta, R, Russo, A, Bogliolo, L, Bajocchi, GL, Bravi, E, Barausse, G, Bortolotti, R, Selmi, CF, Parisi, S, Salaffi, F, Montecucco, C, González-Gay, MA & On Behalf Of Aeneas (American, BOAA 2016, 'Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group', Clinical Reviews in Allergy and Immunology, pp. 1-10. https://doi.org/10.1007/s12016-016-8528-9
Cavagna, Lorenzo ; Nuño, Laura ; Scirè, Carlo Alberto ; Govoni, M. ; Longo, Francisco Javier Lopez ; Franceschini, Franco ; Neri, Rossella ; Castañeda, Santos ; Sifuentes Giraldo, Walter Alberto ; Caporali, Roberto ; Iannone, Florenzo ; Fusaro, Enrico ; Paolazzi, G. ; Pellerito, Raffaele ; Schwarting, Andreas ; Saketkoo, Lesley Ann ; Ortego-Centeno, Norberto ; Quartuccio, Luca ; Bartoloni, Elena ; Specker, Christof ; Pina Murcia, Trinitario ; La Corte, R. ; Furini, Federica ; Foschi, Valentina ; Bachiller Corral, Javier ; Airo, Paolo ; Cavazzana, Ilaria ; Martínez-Barrio, Julia ; Hinojosa, Michelle ; Giannini, Margherita ; Barsotti, Simone ; Menke, Julia ; Triantafyllias, Kostantinos ; Vitetta, Rosetta ; Russo, Alessandra ; Bogliolo, Laura ; Bajocchi, Gian Luigi ; Bravi, E. ; Barausse, Giovanni ; Bortolotti, Roberto ; Selmi, Carlo Francesco ; Parisi, Simone ; Salaffi, F. ; Montecucco, Carlomaurizio ; González-Gay, Miguel A. ; On Behalf Of Aeneas (American, Behalf Of Aeneas (American. / Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome : Review of the Literature and Report of the Experience of AENEAS Collaborative Group. In: Clinical Reviews in Allergy and Immunology. 2016 ; pp. 1-10.
@article{a8f794cab9ab47df95986e92df2f04f3,
title = "Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group",
abstract = "Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD), an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). Recently, we organized an international collaborative group called American and European NEtwork of Antisynthetase Syndrome (AENEAS) for the study of this rare and fascinating disease. The group collected and published one of the largest series of ASSD patients ever described and with one of the longer follow-up ever reported. The number of participating centers is steadily increasing, as well as the available cohort. In the first paper, we showed that arthritis, myositis, and ILD may be frequently the only feature at disease onset, raising problems to reach a correct diagnosis of this syndrome. Nevertheless, we first observed that the ex novo appearance of further manifestations is common during the follow-up, strengthening the importance of a correct diagnosis. In our cohort, the 24 {\%} of the 243 patients up to now collected had isolated arthritis as a presenting feature. These patients represent the most intriguing group in terms of differential diagnosis and clinical time course. Furthermore, data on this aspect are scanty, the reason that lead us to evaluate these aspects in our cohort of patients, reviewing also available literature. In fact, the most relevant aspect is that ASSD is rarely suspected in this setting of patients, in particular in case of poliarticular involvement, positive rheumatoid factor (RF), or anti-cyclic citrullinated peptide antibodies (ACPA) or evidence of joint erosions at plain radiographs. These findings were not rare in our cohort, and they have been also described in other series. Furthermore, manifestations such as Raynaud’s phenomenon, mechanic’s hands, and fever that may lead to the suspect of ASSD are observed only in a third of cases. If we consider the high rate of clinical picture progression in these patients, we feel that ASSD should be carefully considered in all patients presenting with isolated arthritis, even in those with erosive, RF, and ACPA-positive arthritis.",
keywords = "Anti-cyclic citrullinated peptide, Anti-Jo-1, Antisynthetase syndrome, Clinical time course, Isolated polyarthritis, Rheumatoid factor",
author = "Lorenzo Cavagna and Laura Nu{\~n}o and Scir{\`e}, {Carlo Alberto} and M. Govoni and Longo, {Francisco Javier Lopez} and Franco Franceschini and Rossella Neri and Santos Casta{\~n}eda and {Sifuentes Giraldo}, {Walter Alberto} and Roberto Caporali and Florenzo Iannone and Enrico Fusaro and G. Paolazzi and Raffaele Pellerito and Andreas Schwarting and Saketkoo, {Lesley Ann} and Norberto Ortego-Centeno and Luca Quartuccio and Elena Bartoloni and Christof Specker and {Pina Murcia}, Trinitario and {La Corte}, R. and Federica Furini and Valentina Foschi and {Bachiller Corral}, Javier and Paolo Airo and Ilaria Cavazzana and Julia Mart{\'i}nez-Barrio and Michelle Hinojosa and Margherita Giannini and Simone Barsotti and Julia Menke and Kostantinos Triantafyllias and Rosetta Vitetta and Alessandra Russo and Laura Bogliolo and Bajocchi, {Gian Luigi} and E. Bravi and Giovanni Barausse and Roberto Bortolotti and Selmi, {Carlo Francesco} and Simone Parisi and F. Salaffi and Carlomaurizio Montecucco and Gonz{\'a}lez-Gay, {Miguel A.} and {On Behalf Of Aeneas (American}, {Behalf Of Aeneas (American}",
year = "2016",
month = "1",
day = "19",
doi = "10.1007/s12016-016-8528-9",
language = "English",
pages = "1--10",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",

}

TY - JOUR

T1 - Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome

T2 - Review of the Literature and Report of the Experience of AENEAS Collaborative Group

AU - Cavagna, Lorenzo

AU - Nuño, Laura

AU - Scirè, Carlo Alberto

AU - Govoni, M.

AU - Longo, Francisco Javier Lopez

AU - Franceschini, Franco

AU - Neri, Rossella

AU - Castañeda, Santos

AU - Sifuentes Giraldo, Walter Alberto

AU - Caporali, Roberto

AU - Iannone, Florenzo

AU - Fusaro, Enrico

AU - Paolazzi, G.

AU - Pellerito, Raffaele

AU - Schwarting, Andreas

AU - Saketkoo, Lesley Ann

AU - Ortego-Centeno, Norberto

AU - Quartuccio, Luca

AU - Bartoloni, Elena

AU - Specker, Christof

AU - Pina Murcia, Trinitario

AU - La Corte, R.

AU - Furini, Federica

AU - Foschi, Valentina

AU - Bachiller Corral, Javier

AU - Airo, Paolo

AU - Cavazzana, Ilaria

AU - Martínez-Barrio, Julia

AU - Hinojosa, Michelle

AU - Giannini, Margherita

AU - Barsotti, Simone

AU - Menke, Julia

AU - Triantafyllias, Kostantinos

AU - Vitetta, Rosetta

AU - Russo, Alessandra

AU - Bogliolo, Laura

AU - Bajocchi, Gian Luigi

AU - Bravi, E.

AU - Barausse, Giovanni

AU - Bortolotti, Roberto

AU - Selmi, Carlo Francesco

AU - Parisi, Simone

AU - Salaffi, F.

AU - Montecucco, Carlomaurizio

AU - González-Gay, Miguel A.

AU - On Behalf Of Aeneas (American, Behalf Of Aeneas (American

PY - 2016/1/19

Y1 - 2016/1/19

N2 - Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD), an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). Recently, we organized an international collaborative group called American and European NEtwork of Antisynthetase Syndrome (AENEAS) for the study of this rare and fascinating disease. The group collected and published one of the largest series of ASSD patients ever described and with one of the longer follow-up ever reported. The number of participating centers is steadily increasing, as well as the available cohort. In the first paper, we showed that arthritis, myositis, and ILD may be frequently the only feature at disease onset, raising problems to reach a correct diagnosis of this syndrome. Nevertheless, we first observed that the ex novo appearance of further manifestations is common during the follow-up, strengthening the importance of a correct diagnosis. In our cohort, the 24 % of the 243 patients up to now collected had isolated arthritis as a presenting feature. These patients represent the most intriguing group in terms of differential diagnosis and clinical time course. Furthermore, data on this aspect are scanty, the reason that lead us to evaluate these aspects in our cohort of patients, reviewing also available literature. In fact, the most relevant aspect is that ASSD is rarely suspected in this setting of patients, in particular in case of poliarticular involvement, positive rheumatoid factor (RF), or anti-cyclic citrullinated peptide antibodies (ACPA) or evidence of joint erosions at plain radiographs. These findings were not rare in our cohort, and they have been also described in other series. Furthermore, manifestations such as Raynaud’s phenomenon, mechanic’s hands, and fever that may lead to the suspect of ASSD are observed only in a third of cases. If we consider the high rate of clinical picture progression in these patients, we feel that ASSD should be carefully considered in all patients presenting with isolated arthritis, even in those with erosive, RF, and ACPA-positive arthritis.

AB - Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD), an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial lung disease (ILD). Recently, we organized an international collaborative group called American and European NEtwork of Antisynthetase Syndrome (AENEAS) for the study of this rare and fascinating disease. The group collected and published one of the largest series of ASSD patients ever described and with one of the longer follow-up ever reported. The number of participating centers is steadily increasing, as well as the available cohort. In the first paper, we showed that arthritis, myositis, and ILD may be frequently the only feature at disease onset, raising problems to reach a correct diagnosis of this syndrome. Nevertheless, we first observed that the ex novo appearance of further manifestations is common during the follow-up, strengthening the importance of a correct diagnosis. In our cohort, the 24 % of the 243 patients up to now collected had isolated arthritis as a presenting feature. These patients represent the most intriguing group in terms of differential diagnosis and clinical time course. Furthermore, data on this aspect are scanty, the reason that lead us to evaluate these aspects in our cohort of patients, reviewing also available literature. In fact, the most relevant aspect is that ASSD is rarely suspected in this setting of patients, in particular in case of poliarticular involvement, positive rheumatoid factor (RF), or anti-cyclic citrullinated peptide antibodies (ACPA) or evidence of joint erosions at plain radiographs. These findings were not rare in our cohort, and they have been also described in other series. Furthermore, manifestations such as Raynaud’s phenomenon, mechanic’s hands, and fever that may lead to the suspect of ASSD are observed only in a third of cases. If we consider the high rate of clinical picture progression in these patients, we feel that ASSD should be carefully considered in all patients presenting with isolated arthritis, even in those with erosive, RF, and ACPA-positive arthritis.

KW - Anti-cyclic citrullinated peptide

KW - Anti-Jo-1

KW - Antisynthetase syndrome

KW - Clinical time course

KW - Isolated polyarthritis

KW - Rheumatoid factor

UR - http://www.scopus.com/inward/record.url?scp=84954525662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954525662&partnerID=8YFLogxK

U2 - 10.1007/s12016-016-8528-9

DO - 10.1007/s12016-016-8528-9

M3 - Article

SP - 1

EP - 10

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

ER -